Active, not recruiting
VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease
NCT06874621
- Conditions
- Alzheimer's Disease (AD)
- Locations
-
- VYGR Site 840018 Los Angeles, California, United States
- VYGR Site 840016 Orange, California, United States
- VYGR Site 840022 San Francisco, California, United States
- VYGR Site 840008 Stamford, Connecticut, United States